ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
$54
About Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Details
Daily high
$13.85
Daily low
$12.79
Price at open
$12.87
52 Week High
$25.88
52 Week Low
$8.04
Market cap
348.5M
Dividend yield
0.00%
Volume
397,046
Avg. volume
496,741
P/E ratio
-5.09
Arcturus Therapeutics Holdings Inc. - Common Stock News
Details
Daily high
$13.85
Daily low
$12.79
Price at open
$12.87
52 Week High
$25.88
52 Week Low
$8.04
Market cap
348.5M
Dividend yield
0.00%
Volume
397,046
Avg. volume
496,741
P/E ratio
-5.09